Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gompels

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
International Journal of STD & AIDS|May 17, 2008
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)E J Beck, S Mandalia, M Youle, et al.
The Quarterly Journal of Medicine|June 1, 1992
A study of neuropathy in HIV infectionJ B Winer, B Bang, J R Clarke, et al.
Journal of Clinical Pathology|October 1, 1991
Disseminated pneumocystis carinii infection in AIDSR J Coker, D Clark, E L Claydon, et al.
HIV Medicine|November 20, 2013
The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrationsM Samuel, S Jose, A Winston, et al.
Clinical and Experimental Immunology|February 26, 2005
C1 inhibitor deficiency: consensus documentM M Gompels, R J Lock, M Abinun, et al.
HIV Medicine|October 6, 2020
Estimated glomerular filtration rate slopes on tenofovir alafenamideF Ibrahim, L Campbell, A C Bailey, et al.
Bjpsych Open|May 17, 2017
Clinically significant depressive symptoms and sexual behaviour among men who have sex with menAda R Miltz, Alison J Rodger, Janey Sewell, et al.
HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.
HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.
HIV Medicine|November 24, 2011
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UKC Kober, M Johnson, M Fisher, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
International Journal of STD & AIDS|May 17, 2008
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)E J Beck, S Mandalia, M Youle, et al.
The Quarterly Journal of Medicine|June 1, 1992
A study of neuropathy in HIV infectionJ B Winer, B Bang, J R Clarke, et al.
Journal of Clinical Pathology|October 1, 1991
Disseminated pneumocystis carinii infection in AIDSR J Coker, D Clark, E L Claydon, et al.
HIV Medicine|November 20, 2013
The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrationsM Samuel, S Jose, A Winston, et al.
Clinical and Experimental Immunology|February 26, 2005
C1 inhibitor deficiency: consensus documentM M Gompels, R J Lock, M Abinun, et al.
HIV Medicine|October 6, 2020
Estimated glomerular filtration rate slopes on tenofovir alafenamideF Ibrahim, L Campbell, A C Bailey, et al.
Bjpsych Open|May 17, 2017
Clinically significant depressive symptoms and sexual behaviour among men who have sex with menAda R Miltz, Alison J Rodger, Janey Sewell, et al.
HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.
HIV Medicine|February 12, 2010
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populationsL Bansi, C Sabin, V Delpech, et al.
HIV Medicine|November 24, 2011
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UKC Kober, M Johnson, M Fisher, et al.
Pageof 9